Home | Online Registration | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London 2019
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
2019 Speaker List
2018 Peer Review Board Members
Delegate Information
2019 VENUE: The Kensington Town Hall - MAP
Nearby London Accommodations
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
Past Conference Information
2018 Speakers and Presentations
2018 Programme
2018 Exhibitors

BSAAMs AACL 2018 Peer Review Board Members
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  Past Speakers 2004
  Past Speakers Monte Carlo 2002
BSAAM's AACL Organizer
BSAAM Affiliates
AACL Supporters
HB Health
  Sun Chlorella

AACL 2007 Speaker

WainrightMr Walter H Wainright
Founder and Chief Counselor for Haelan Research Foundation, a United States Government approved 501(c) (3) Public Foundation.

Mr. Wainright, an honors graduate of Tulane University, is an internationally known lecturer with 17 years experience in researching the prevention and treatment of cancer and other chronic diseases with soy phytochemicals. Mr. Wainright’s research has received recognition by the National Cancer Institute (USA) and is currently being researched at the M.D. Anderson Cancer Center in the United States and several leading cancer centers in Europe. Mr. Wainright is collaborating with the Institute for molecular oncology in Recklinghausen, Germany on reversing DNA damage in cancer cells with soy phytochemicals. He has designed and completed clinical trials in Asia, Europe and the United States showing the human health benefits of dietary soy phytochemicals.  His research and experience with humans documents the benefits of soy therapy for estrogen receptor positive breast, prostate and other cancers.  Mr. Wainright’s research also addresses how the soy phytochemicals protect cancer patients from chemotherapy induced cell mutations, related toxicity, infections and anemia as well as enhanced cancer cell killing effectiveness 8-10 times greater than chemotherapy treatments by themselves.

2007 - Are Soy Phytoestrogens Ideal for Preventing Chronic Diseases and Treating Cancer?

There are more than 4,400 Phytoestrogens in the plant kingdom.  None have been researched more than the soy-phytoestrogens for their beneficial health effects. Epidemiological studies clearly show lower cancer (breast, prostate, ovarian) and other chronic diseases in Asian countries with high intake of Isoflavones. Conclusions from soy studies have been controversial because uniformity has been lacking in what constitutes a “soy” study.  Whole soy versus soy protein or isolates from soy; fermented soy versus unfermented soy; concentrations and types of soy Isoflavones and/or their metabolites are different in studies.  All soy products are not equal and results vary depending on the soy composition and its processing. 

Eighty percent of advanced cancer patients die from protein calorie malnutrition. This condition is enhanced by the toxic side effects of chemotherapy and radiation treatments which promote mal absorption, fatigue, nausea, vomiting, depression and stress that further decreases immune function and the patient’s will to live.  In the field of cancer, fermented soy proteins and photochemicals are establishing a strong position for their incorporation in the cancer patient’s diet. The National Cancer Institute has documented, as part of its “Best Case Series” program, sole therapy treatment with fermented soy improves both the quality of life and lifespan of terminal cancer patients. Some terminal cancer patients became cancer free and remained cancer free for more than five years.   

A $20 million NCI study in fruits and vegetables discovered five effective classes of anti-cancer compounds. All are in soybeans!  These were identified as isoflavones, protease-inhibitors, phytosterols, saponine and phytic-acid compounds. The soybean contains anti-viral, anti-allergy, anti-inflammatory, vasodilator, and anti-cancer compounds.  There are more than 9,000 studies on soy and its beneficial compounds performed since the NCI published there paper in April, 1991. Many of these studies show that unfermented soy products have drawbacks contrary to fermented soy that indicated to be more beneficial. The mechanisms of action include DNA repair, anti-angiogenesis, restoration of apoptosis, immune stimulation, detoxification, improved estrogen metabolism, enhanced organ function, reduction of cell division times (mitosis), suppression of cancer  promoting genes,  and prevention of cancer cell mutations induced by chemotherapy.

Conclusion:  Fermented soy products are known to contain high concentrations of Isoflavones, protease inhibitors, saponine, phytosterols, and phytic acid compounds that exhibit anticancer activity in preclinical models.  Research supports the prospective evaluation of fermented soy products as an alternative therapy in patients with chemotherapy refractory ovarian cancer and other cancers that are not responsive to chemotherapy.  The use of these products to enhance chemotherapy, reduce toxic effects of chemotherapy and prevent mutations induced by chemotherapy offers new hope for many patients.  In addition, these products can help the physician manage disease while it is treated with conventional therapies resulting in improved treatment compliance and patient outcomes.  The greater role of soy phytoestrogens and the other soy compounds may be found in the field of anti-aging and preventive medicine because of their ability to repair DNA resulting in the prevention of diseases or improvement in disease conditions caused by existing DNA damage.


Home | Online Registration | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :